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AKTIVITI BIOLOGI ACANTHOPHORA SPICIFERA (VAHL) BORGESEN 
DARI PULAU GEDUNG, PULAU PINANG  
 
 
ABSTRAK 
 
Lapan ekstrak daripada Acanthophora spicifera yang diperolehi dari dua 
kaedah pengekstarakan menggunakan pelarut yang bebeza kekutuban telah 
digunakan. Ekstrak tersebut di uji untuk menentukan aktiviti antimikrob, 
antioksidan, ketoksikan in-vitro dan juga kandungan sebatian fenolik. Kebanyakan 
ekstrak menunjukkan aktiviti antibakteria ke atas bakteria kajian. Tiada aktiviti 
antikulat ditunjukkan terhadap kulat kajian. Ekstrak kasar metanol mempamerkan 
aktiviti antibakteria yang menarik terhadap bakteria Gram-negatif, Pseudomonas 
aeruginosa ATCC 27853 dengan zon perencatan sebanyak 11.0 mm, nilai MIC 250 
µg mL-1 dan nilai MBC 500 µg mL-1. A. spicifera juga menunjukkan aktiviti 
antioksidan. Ekstrak kloroform menunjukkan aktiviti antioksidan tertinggi dengan 
50% penyingkiran radikal bebas sebanyak 789.0 µg mL-1, manakala piawai yang 
digunakan iaitu quercetin sebanyak 3.361 µg mL-1. Manakala untuk kandungan total 
fenolik, ekstrak etil asetat menunjukkan kandungan fenolik tertinggi sebanyak 
(40.58 ± 1.16 µg GAE mg-1 ekstrak kering). Kesemua ekstrak yang diuji juga 
menunjukkan korelasi linear positif di antara aktiviti antioksidan dan kandungan 
fenolik. Ekstrak kasar methanol juga mempamerkan aktiviti ketoksikan yang 
signifikan terhadap anak udang, Artemia salina dengan nilai kepekatan maut 50% 
akut pada 635.47 µg mL-1dan kronik pada 275.72 µg mL-1. Ekstrak ini 
kemudiannya, difraksi menggunakan kromatografi turus gel silika dengan 
menggunakan campuran pelarut heksana dan etil asetat sebagai fasa bergerak dan 
 xiv 
 
menghasilkan 15 fraksi (af1-af15) keseluruhannya. Hanya tiga fraksi (af14, af15, 
af7) didapati aktif terhadap P. aeruginosa ATCC 27853 dengan nilai MIC di antara 
125-250 µg mL-1. Oleh kerana kekurangan hasil fraksi af15 dan af7, hanya fraksi 
aktif af14 sahaja yang dilakukan pemfraksian lanjut. Hasil sub-fraksi (aff2) daripada 
pemfraksian fraksi af14 yang aktif terhadap P. aeruginosa ATCC 27853 dengan 
nilai MIC 75 µg mL-1 kemudiannya dianálisis dengan LC-MS dan GC-MS. Hasil 
análisis GC-MS mendapati kehadiran sebatian hidrokarbon, asid lemak, ester asid 
aromatik dikarbosilat, sebatian benzena dan lain- lain. Walau bagaimanapun, 
sebatian aktif yang terpisah dari aff2 tidak dapat dikenalpasti berdasarkan analisis 
LC-MS.  
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BIOLOGICAL ACTIVITIES OF ACANTHOPHORA SPICIFERA (VAHL) 
BORGESEN FROM PULAU GEDUNG, PENANG 
 
 
 
 
ABSTRACT 
 
 
A total of eight extract of Acanthophora spicifera extracted using two 
different methods using solvents of different polarity, were used throughout this 
study. These extracts were assayed to determine the antimicrobial activities, 
antioxidant activities, in-vitro cytotoxicity and total phenolic contents. Most of the 
extracts exhibited antibacterial activity against the tested bacteria. Meanwhile, no 
antifungal activity was observed on tested fungi. Among the extract, crude methanol 
extract demonstrated promising antibacterial activity against Gram-negative 
Pseudomonas aeruginosa ATCC 27853 with inhibition zone of 11.0 mm, MIC 
values of 250 µg mL-1 and MBC value of 500 µg mL-1. A. spicifera also exhibited 
antioxidant properties. Chloroform extract was found to exhibit the highest DPPH 
free radical scavenging activity with LC50 of 789 µg mL-1, while standard quercetin 
used is 3.361 µg mL-1. Meanwhile, for total phenolic contents, ethyl acetate extract 
gave the highest phenol contents (40.58 ± 1.16 µg GAE mg-1 dry extract). All 
extracts also showed good positive linear correlation between the antioxidant 
activities and total phenolic content, proving the role of phenolics as the main 
compounds for antioxidants. Crude methanol extract also exhibited significant 
toxicity effects on brine shrimp, Artemia salina with LC50 value obtained for acute 
and chronic was 635.47 µg mL-1 and 275.72 µg mL-1, respectively. The crude 
methanol extract was later fractionated using silica gel column chromatography 
using a mixture of hexane and ethyl acetate as the mobile phase, yielding a total of 
 xvi 
 
15 fractions (af1-af15). Only three fractions (af14, af15 and af7) were found active 
against P. aeruginosa ATCC 27853 with the MICs ranging from 125-250 µg ml-1. 
However, due to inadequate amount of fractions collected (af15 and af7), only active 
fraction of af14 was further fractionated. Sub-fraction (aff2) of the active fraction of 
af14 which active against P. aeruginosa ATCC 27853 with the MIC of 75 µg mL-1 
was analyze using LC-MS and GC-MS. The GC-MS analysis has identified the 
presence of hydrocarbons, fatty acids, aromatic dicarboxylate acid ester, benzene 
compounds and others. However, the active compounds were not being able to be 
identified based on mass spectral data from LC-MS analysis.  
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CHAPTER 1  
 
INTRODUCTION 
 
1.1      Acanthophora spicifera (Vahl) Borgesen 
1.1.1 Morphological description 
 
Figure 1.1 Acanthophora spicifera (Vahl) Borgesen 
 
Acanthophora spicifera (Vahl) Borgesen is a common tropical and subtropical red 
alga (Kilar and McLachlan, 1986). It is an erect marine plant with growing height up 
to approximately 25-40 cm tall. It is also known as spiny seaweed due to the 
presence of numerous spines on its branches. The spines are arranged in radial order 
at all the branches except the main axes. The branches (2-3 mm in wide) are solid 
with a cylindrical and sharp tip ends. This algal has a wide spread distribution as it 
can grow either in a scattered clump as free floating algae or attached to other 
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substrates using the holdfast, such as on reefs and intertidal habitat area. A. spicifera 
also have a high tolerance against strong wave and water motion in which influences 
the size and morphology (colours and length of thalli). It can appear to be as shades 
of red, yellow, orange and brown. In intertidal and high water motion areas, the 
colours are normally darker, while lighter in shallow areas with low water motion 
(University of Hawaii, 2001). This alga belongs to the largest Rhodophyta family, 
Rhodomelaceace (Table 1.1).  
 
    Table 1.1 Taxonomy of A. spicifera  
Kingdom Plantae 
Subkingdom Biliphyta 
Phylum Rhodophyta 
Subphylum Eurhodophytina 
Class Florideophyceae 
Order Ceramiales 
Family Rhodomelaceae 
Genus Acanthophora 
Species Acanthophora spicifera 
 
    (Source: Jong et al., 1999) 
 
 
1.1.2 Utilization and therapeutic values 
 
In Fiji, A. spicifera is widely used in diets (Payri et al., 2000; South, 1993) as it 
generally exhibited non-starch polysaccharides, minerals and vitamins (Devi et al., 
2009). While, in some part of Philippines (Trono, 1999), and Indonesia (Chorus and 
Bartram, 1999), A. spicifera are collected and eaten either as fresh raw vegetables or 
blanched in salads. In India, Acanthophora sp. is used as flavors in preparation of 
porridge (Dhargalkar and Pereira, 2005). Trono (1999) stated that, young shoots of 
A. spicifera serve as food thickening and flavouring agent in cooking, mainly in 
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soups. It was also reported that A. spicifera contain carrageenan, which is a suitable 
ingredient to be used in foods and non-foods products (Devi et al., 2009).  
 
As for this local alga, little is known due to the limited research performed. 
According to Burkhill (1966), the consumption of A. spicifera as foods has been 
recorded in Philippine and Java (Indonesia) but not in Malaya. Also, none of the 
previous research outlined the usage of this local red alga for traditional medicine. 
Despite the lack of information regarding the utilization of this algae as foods and 
traditional medicine, various studies conducted in other countries have recognized 
the therapeutic values of A. spicifera for its antibiotic properties against various 
microorganisms (Gupta et al., 1991; Tuney et al., 2006), antiviral (Duarte et al., 
2004) and as an anti-fertility agent (Wahidulla et al., 1986).  A. spicifera is also used 
as feeding material for abalone (Phang, 2006).  
 
1.1.3 Phytochemical constituents and bioactivity  
 
Although study of A. spicifera on its chemical constituents is still a few in Malaysia, 
various previous study have reported the chemical constituents of A. spicifera 
studied in other countries. This bioactive compound was also evaluated using 
bioassays to investigate the biological properties. Some of the previous studies 
conducted on the phytochemical constituents and bioactivity of A. spicifera is shown 
in Table 1.2 
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Table 1.2 Phytochemical constituents and bioactivity of A. spicifera 
Bioactive compounds Bioactivity References 
Sterols: 6-hydroxycholest-4-ene-
3-one, cholest-4-ene-3, 6-dione, 
5 alpha-cholestane-3, 6-dione 
 
Cytotoxicity against 
human cancer  cell line 
Han et al. (2009) 
Flavonoids: kaempferol 3-O-α-
L-fucopyranoside and quercetin 
3-O-α-L-fucopyranoside 
 
Antibacterial activity, 
antioxidant activity 
Zheng et al. (2010) 
Sulfated agaran Antiviral activity Duarte et al. (2004) 
 
 
 
1.2 The needs of drugs from natural products 
 
The uses of medicinal plants and herbs for therapeutic purposes have long started 
before the discovery of antibiotics by ancient peoples. The ancient peoples relies on 
their immune system and also organic and inorganic natural remedies namely, 
honey, molds, wine, vinegar, copper and others to treat infections and wounds 
(McKenna, 1998). The uses of the herbs and plants for medicinal purposes were 
widely practiced especially in rural area, where 65-80% of the world’s population 
relies on it to treat ailments such as open wounds and others (WHO, 2002). 
Unfortunately, not all infections can be cured using the traditional medicines, thus 
the needs of antibiotics take place. 
 
The rise of antibiotic resistance bacteria also added to the crucial needs of drugs 
from nature. According to Sorum (2006), one of the major outbreaks of the 
emergences of resistance strains was marked by Shigella sp. during the epidemics 
outbreak of bacillary dysentery in Japan.  In 1950s, plasmid that contained the 
resistant gene, known as R-plasmid was found residing in the dysentery agent, 
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Shigella sp. which was reported to be resistant to sulfonamide antibiotics. 
Sulfonamides are the most common antibiotics used to treat dysentery during that 
time. The capability of Shigella sp. to transfer the R-plasmid to other, made the 
treatment with sulfonamides failed and hence resulted in increasing the resistant 
strains. Later, the resistance of Shigella sp was widespread in Japan whereby, they 
were found resistant against four types of antibiotics, namely sulfonamides, 
chloramphenicol, tetracycline and streptomycin. As a consequent, the choices of 
effective treatments become narrow. This rapid increased of the resistant strains may 
overhead the drug discovery itself. Thus, it has alarmed researchers in continuous 
searching for alternative and novel antibiotics especially form natural products for 
the better future. 
 
Moreover, the health concerns regarding toxicity, carcinogenicity and potential 
hazards of synthetic antibiotics and antioxidants such as butylated hydroxytoluene 
(BHT) and butylated hydroxyanisole (BHA) to living organisms, have triggered the 
search for new compounds from natural derivatives as a replacement which is 
naturally safer than the chemically synthesized compounds (Safer and al-
Nughamish, 1999).  
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1.3 Potential drugs from natural products 
 
Natural products from plants, microorganisms and algae are undoubtedly the most 
important sources in drug discoveries. United States Food and Drug Administration 
(FDA) reported in Annual Reports of Medical Chemistry from 1983-1994, that 
60%-75% drugs in infectious diseases and cancer were derived from natural origin 
(Newman et al., 2003). Among the natural products, algae have become the interest 
of current trends in drugs research as they exhibited numerous active compounds 
with promising biological activities. This remarkable active compounds secreted by 
the algae are known as secondary metabolites as they are not involved in the basic or 
primary functions of life (Cimino and Ghiselin, 2001). Marine algae secreted wide 
varieties of secondary metabolites such as peptides, terpenes, indoles, polyketides, 
volatile halogenated hydrocarbons and others (Butter and Sandy, 2009). Various 
studies have been conducted over the past decades to validate the biological 
properties of these secondary metabolites such as antimicrobial, antioxidant, 
antifouling, antiproliferative, antitumor and cytotoxic activity of the algae crude 
extracts (Blunt et al., 2009). 
 
Algae also produced halogenated compounds that play various roles such as, a 
defense mechanism against grazer and pathogens, against microorganism infections, 
for competing for space, mate recognition and prey detection (Goodwin et al., 1997; 
Duarte et al., 1999; Paul and Ritson-Williams, 2008; Hay, 2009). Studies on the 
importance of these secondary metabolites as a defense mechanism might be useful 
in searching for new drugs against pathogenic microorganism. Besides, it might 
become a platform to the development of potential novel drugs. 
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1.3.1      Seaweeds as source of drugs 
 
Seaweeds have been known as one of the richest and most promising sources of 
bioactive secondary metabolites from sea which represent about 9% of compounds 
found from the sea (Baslow, 1969; Smith, 1977).  These bioactive compounds with 
various structures and novel mechanisms of action exhibited wide range of 
biological functions namely, antimicrobial, antioxidant, antifouling, anti-
inflammation and others. Thus, the search for new and natural alternative drugs with 
the algae as the focused of studies have been the interest among researchers 
worldwide. Several example of drugs derived from algae was shown in Table 1.3 
 
An example of an interesting drugs discovered from algae is Phycocyanin (Pc) 
(Figure 1.2). Phycocyanin is a phycobiliprotein that is found as major pigment in 
Spirulina sp. (blue green algae) which have been reported to exhibit various 
pharmacological properties such as antioxidant activity, anti-inflamatory, 
neuroprotective and hepaprotective effects (Romay et al., 2003). Finding by Romay 
et al. (2003) reported that, Pc was effective in scavenging alkoxyl, peroxyl and 
hydroxyl radicals and also able to react with other oxidants like peroxinitrate. Pc 
also reduces inflammatory effects by reducing edema and prostaglandin level in the 
inflamed tissues. Due to its nutritional and therapeutical values, Pc is used as dietary 
supplements. 
 
Figure 1.2  Chemical structure of phycocyanin bilin chromophore 
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Table 1.3 Drugs derived from algae 
Drug Structure Pharmacological function Derivatives 
Phenethylamine  
 
Antidepressants, 
Stimulants, 
hallucinoges 
Gracilaria bursa-pastoris, 
Ceramium rubrum 
Tyramine 
 
Stimulants for central nervous system Laminaria sacclarina,  
Chondrus crispus 
Dopamine 
 
Hormon, neurotransmitter, tread cardiovascular 
and kidney disorder 
Monostroma fuscum 
Martensine A 
 
Antibacterials Martensia fragilis 
Fragilamide  
 
Antioxidants Martensia fragilis 
 
(Source: Guven et al., 2010)
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1.4       Selection of Acanthophora spicifera 
 
In Malaysia, there is a few study conducted on the nutritional value compositions 
and biological properties of Acanthophora spicifera namely proximate composition 
analysis, antimicrobial activity, antioxidant activity and in-vitro toxicity on Artemia 
salina. Studies conducted in Malaysia are more focusing on the ecological study 
(Phang, 1984; Phang, 1998; Mijan Uddin et al., 2007). Whereby, other biological 
studies of A. spicifera have been reported from other countries like Brazil 
(Ballantine et al., 1987; Zubia et al., 2007), and India (Wahidulla et al., 1986; 
Ganesan et al., 2008). Therefore, the initiative is taken to study the biological 
properties of A. spicifera from Malaysian water. Findings of this study will add new 
information on the proximate compositions, antimicrobial activity, antioxidant 
activity, phenolic content and in-vitro toxicity on A. salina of the algae. 
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1.5 Objectives of study 
 
The aims of the present study are as follows: 
1. to extract bioactive compounds from Acanthophora spicifera with two 
different extraction methods; Soxhlet and maceration followed by solvent 
partition using various solvents, and also to screen antimicrobial and 
antioxidant activities, as well as total phenolic contents of the extracts. 
2. to study the in-vitro toxicity on Artemia salina, as well as the Minimum 
Inhibitory Concentration (MIC) and Minimum Bactericidal 
Concentration (MBC) of the extracts. 
3. to study the structural and morphological degeneration of the selected 
bacterial strain treated with the active extract using spectroscopy 
methods: Scanning Electron Microscope (SEM) and Transmission 
Electron Microscope (TEM). 
4. to fractionate the active extract using bioassay guided fractionation.  
5. to identify the active compound using LC-MS and GC-MS. 
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CHAPTER 2  
 
 
LITERATURE REVIEW 
 
 
 
 
2.1 Fading Miracle: The Needs for New Antibiotics 
2.1.1 Declining of antibiotics in pipeline 
 
Despite the glory of the antibiotic discovery over the past 60 years, rapid outgrowth 
of drug resistance pathogens to most commercialized antibiotics have slowly 
overshadowed the success. The on going raised of the resistance has faded the 
effectiveness of antibiotics which gave difficulty in treating infectious diseases 
(Levy, 1992; Walsh and Amyes, 2004). Tenover (2006) also reported that, there is a 
rapid increased in the number of resistant bacteria and diversity of mechanism of 
resistance throughout the years which demanded the needs for new antibiotics 
especially for clinical fields.  
 
Unfortunately, the development of new and effective antibiotics is declining. This 
scenario can be seen as reported by FDA database, where there was a decremented 
of 56% (from 16 to 7) of new antibacterial agent over the past 20 years (1998-2002 
compared to 1983-1987). Since 1998, only 2 out of 9 new classes of antibacterial 
drugs (Linezoid, approved in 2000 and Daptomycin approved in 2003) possessed 
novel mechanism of actions (ECDC, 2009). Besides, in 2004, only 5 (1.6%) of the 
drugs developed by 15 major pharmaceutical companies were antibiotics in which 
none of them were novel class and ineffective against Gram-negative infections 
(Spellberg et al., 2004). Thus, continuous search for effective and novel antibiotics 
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is essential to compliment and to keep pace with the drying up of antibiotics in the 
current pharmaceutical industry. 
 
2.1.2 Antibiotic resistance 
 
The term “antibiotic resistance” refers to the ability of microorganism to evolve or 
withstand the effect of antibiotics (Levy, 1997). Antibiotic resistance was not a new 
phenomenon, because various studies have reported the spread of the resistance. 
According to Martinez (2009) antibiotic resistance is an evolutionary process 
resulted from natural selection which is a good example of Darwinian struggle for 
live theory. The theory stated that, bacteria can adapt and develop resistant towards 
the existing antibiotics over time in order to survive in the presence of 
environmental stress (such as excessive used and dumping of the antibiotics), where 
the strong bacteria continue to grow and spread the resistant genes (Wright, 2007). 
These resistance genes widespread were the results of mutations during the 
replication process or through acquisition of DNA plasmid from other bacteria 
(Dzidic and Bedekovic, 2003). These genes can be acquired by transferring of DNA 
plasmid to others via various mean such as conjugation, transformation and 
transduction process (McManus, 1997). The DNA plasmids hold the key to 
resistance as it encodes the genes or traits responsible for mechanism of resistance. 
The resistance in bacteria can evolved naturally over times due to certain factors 
such as, their naturally high growth rate (fast replication time), ability to acquire 
resistance from other bacteria (Overbye and Barrett, 2009), alteration of target site 
for the antibiotics and pumping out the antibiotics from the cells (Mendonco- Filho, 
2006).  
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In certain case, multi-drug resistance can occur. This situation occurs as bacteria 
become resistance to more than one class of antibiotic introduced, which resulted 
from the transfer of the resistance genes between bacteria (ECDC, 2009). Hence, the 
risen of these mutants bacteria with the enhance ability to survive will continuously 
be emerging (IDSA, 2004; Cars, 2008).  Some examples of the frequent antibiotic-
resistance Gram-positive bacteria are methicillin-resistance Staphylococcus aureus 
(MRSA) and vancomycin-resistant Staphylococcus aureus (Woodford, 2005). 
Pseudomonas aeruginosa is an example of antibiotic-resistance Gram-negative 
bacteria which was found to be resistant to most antibiotics such as β-lactams and 
carbapenem (Slama, 2008). 
 
According to Dzidic and Bedekovic (2003), multiple drugs resistance has become a 
global concern especially in treating nosocomial related infections. It becomes the 
major concern in patients with weak immune systems such as HIV/AIDS patients, 
critical care unit patients and also severely ill patients. Beside, European 
Antimicrobial Resistance Surveillance System (EARSS) (2007) also reported that, it 
was estimated in 2007 that approximately 25 000 patients died from infections 
resulted from the frequent antibiotic-resistant bacteria in Norway, Iceland and 
Europe.  
 
2.1.3 The emergence of diseases and infections 
 
Relationship between emergence of new diseases and antibiotic resistance bacteria 
can be viewed as liner and in dependable manner, wherein the increased number of 
resistance bacteria towards antibiotics has resulted in the emergence of new diseases 
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and pathogens (Levy, 1997). Thus, the fight between human and pathogens have 
never been resolved. Today, increasing infections caused by the resistant pathogens 
have become one of the major public threats. According to WHO (2004), infectious 
diseases are the second major caused of death worldwide following cardiovascular 
diseases which accounted for 26% of 57 million deaths worldwide in 2002. The 
word “emergence” can be defined as newly appeared or already existed disease and 
infections in population and which are gradually increasing (Morse and 
Schluederberg, 1990; Morse, 1993). Some examples of current leading killing 
infectious diseases worldwide are HIV/AIDS, malaria and tuberculosis. Whereby, 
new infections currently reported were the Severe Acute Respiratory Syndrome 
(SARS), West Nile virus and influenza viruses (NIAID, 2007).  
 
There are numerous factors that contributed to their emergence such as, biotic and 
abiotic factors. Biotic factors that might involves are the microbial adaptation and 
evolution to acquire the resistant genes via gene transfer (D’ Agata et al., 2008) and 
also immune response of the host cell while, misuse and uncontrolled usage of 
antibiotics in the treatment of human infections are the abiotic factors that leads to 
the emergence of the resistance strains and infections (Idomir et al., 2009).  
 
The rise of resistance and emergence of new diseases and infections worldwide, 
leads to the higher health care costs especially in treating the nosocomial infections. 
This is because, more new and expensive drugs are required as well as longer 
treatment and diagnosis needed in which results in prolonged stays in the hospital. 
Thus, there is a crucial need for continuous research. Understanding the mechanism 
of reaction between the host and pathogens as well as collecting the valuable data 
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are required in order to develop and improve the treatments, vaccines and 
diagnostics.  
 
2.2 History of antibiotic discovery 
 
In a broad term, antibiotics are a type of antimicrobial drug which are effective in 
small concentration to inhibit or kills the growth of microorganism including 
bacteria, viruses, fungi, yeasts, protozoa, and parasites (IDSA, 2004).  The 
development of antibiotics throughout the years is shown in Table 2.1. 
 
       Table 2.1 Discovery of the antibiotics 
Year Antibiotic discovery 
1930s Sulfonamides 
1940s Aminoglycosides 
 Beta-lactams 
1950s Chloramphenicol 
 Tetracyclines 
 Macrolides 
 Glycopeptides 
1960s Strepogramins 
 Quinolones 
 Lincosamides 
1970s Trimethoprim 
1980s - 
1990s - 
2000s Lipopeptides 
 Oxazolidinones 
 
       Source: ECDC (2009). 
 
The golden age of antibiotics started with the discovery of sulfonamides, penicillin 
and streptomycin in 1930s-1940s. Penicilin was the first beta-lactams (β-lactam) 
discovered by Alexander flaming in 1940s, from Penicillium sp.. This success was 
then followed by the development of chloramphenicol, tetracylines, macrolides and 
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glycopeptides in 1950s. The development of antibiotics was stable enough between 
1930s to 1970s, as most of the antibiotics were discovered (Jagusztyn-Krynicka and 
Wyszynska, 2008). The antibiotic era started to enter declining phase at late 1970s 
to early 2000s, where only two classes of antibiotics (daptomycin and linezolid) 
were discovered. Daptomycin, was a cyclic lipopeptide derived from Streptomyces 
roseosporus while, linezolid was a synthetic antibiotic belongs to oxazolidinones. 
Both drugs were found effective against bacteria that were resistant against 
methicilin or vancomycin antibiotics (Pucci, 2006; Wright, 2007). 
 
2.3 Types of antibiotics and mechanisms of action 
 
There are three source of origin where antibiotics are derived from, which are 
natural, semi-synthetic and synthetic. The chemically modified natural antibiotics 
(semi-synthetic and synthetic) are done to enhance its efficacy (Madigan et al., 
2009). Most of the antibiotics produced today are derived from natural products 
(Newman and Cragg, 2007). These types of antibiotics can be classified into 
different classes according to their mode of actions, which varies between classes. 
Some of the major classes of antibiotics are β-lactams, tetracyclines, macrolides, and 
aminoglycosides.  
 
Besides, antibiotics also can be classified according to their target group of 
microorganisms such as antibacterial, antifungal and antiviral agents (Sasidharan, 
2006). Moreover, spectrum of activity of the antibiotics could also be used for 
classifications which are either broad or narrow spectrums. Broad spectrum 
antibiotics are able to react active against wide range of microorganisms (both 
17 
 
Gram-positive and Gram-negative bacteria) whereas, a narrow spectrum antibiotics 
only target a specific group of microorganism (either Gram-positive or Gram-
negative bacteria). An effective antibiotic must have a good selective toxicity, where 
it only causes harm to the target microbes and not the host cells. 
 
2.3.1 Antibacterial drugs 
 
Antibacterial drugs only exert their effect on bacteria. The antibacterial antibiotics 
are classified based on their mode of action either bacteriostatic or bactericidal. 
Bacteriostatic antibiotics act by inhibiting the growth of bacteria wherein, 
bactericidal antibiotics kill bacteria. Different types of antibacterial drugs have 
different mechanism of actions. Generally, there are five mechanisms which are 
inhibition of cell wall synthesis, inhibition of protein synthesis, interference in 
metabolic pathway, nucleic acids synthesis and also disrupting the cell membrane. 
The different classes of antibiotics and summary of the mechanism action are shown 
in Table 2.2. 
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Table 2.2 Summary of antibiotics type, action and classes (Dzidic et al., 2008; Kohanski et al., 2010) 
Class Drug Derivation Species range Primary target Pathway affected 
Fluoroquinolones      
DNA synthesis 
inhibitor 
Nalidixic acid, 
ciprofloxacin, 
levofloxacin and 
gemifloxacin 
Synthetic Aerobic Gram-
positive and Gram-
negative species, 
some Anaerobic 
Gram-negative 
species 
(Clostridium 
perfringes) and 
Mycobacterium 
tuberculosis 
Topoisomerase II 
(DNA gyrase), 
topoisomerase IV 
DNA replication, 
SOS response, cell 
division, ATP 
generation, TCA 
cycle, Fe–S cluster 
synthesis, ROS 
formation, and 
envelope and 
redox-responsive 
two-component 
systems 
 
Trimethoprim–
sulfamethoxazole 
     
DNA synthesis 
inhibitor 
Co-trimoxazole 
(a combination of 
trimethoprim and 
sulfamethoxazole 
in a 1:5 ratio) 
 
Synthetic Aerobic Gram-
positive and Gram-
negative species 
Tetrahydrofolic acid 
synthesis inhibitors 
Nucleotide 
biosynthesis and 
DNA replication 
Rifamycins      
RNA synthesis 
inhibitor 
Rifamycins, 
rifampin and 
rifapentine 
Natural and semi-
synthetic forms of 
ansamycins (derived 
from Streptomyces 
mediterranei) 
 
Gram-positive and 
Gram-negative 
species, and 
Mycobacterium 
tuberculosis 
DNA-dependent 
RNA polymerase 
RNA transcription, 
DNA replication 
and SOS response 
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Table 2.2 Continued 
Class Drug Derivation Species range Primary target Pathway affected 
β-lactams*      
Cell wall 
synthesis 
inhibitors 
Penicillins 
(penicillin, 
ampicillin, 
oxacillin), 
cephalosporins 
(cefazolin, 
cefoxitin 
ceftriaxone, 
cefepime) and 
carbapenems 
(imipenem) 
Natural and semi-
synthetic forms of 
carbonyl   lactam ring-
containing azetidinone 
molecules (from 
Penicillum notatum, 
Cephalosporium 
acremonium and 
Streptomyces cattleya) 
Aerobic and 
anaerobic 
Gram-positive and 
Gram-negative 
species 
Penicillin-binding 
Proteins 
Cell wall synthesis, 
cell division, 
autolysin activity 
(regulated by 
LytSR–VncRS-
component system), 
SOS response, TCA 
cycle, Fe–S cluster 
synthesis, ROS 
formation, and 
envelope and redox-
responsive two-
component systems 
Glycopeptides, 
glycolipopeptides 
     
Cell wall 
synthesis 
inhibitor 
Vancomycin; 
teicoplanin 
Natural and semi-
synthetic forms of 
amino sugar-linked 
peptide chains (for 
glycopeptides) or of 
fatty acid-bearing, 
amino sugar-linked 
peptide chains (for 
glycolipopetides) 
derived from 
actinobacteria 
Gram-positive 
species 
Peptidoglycan 
units (terminal 
d-Ala-d-Ala 
dipeptide) 
Cell wall synthesis, 
transglycosylation, 
transpeptidation and 
autolysin activation 
(VncRS two-
component system) 
 
* Drug efficacy can vary across species range based on drug generation. ‡When used as a combination of pristinamycin I and 
pristinamycin II. 
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Table 2.2 Continued 
Class Drug Derivation Species range Primary target Pathway affected 
Lipopeptides      
Cell wall 
synthesis 
inhibitors 
Daptomycin and 
polymixin B 
Natural and semi-
synthetic forms of 
fatty acid-linked 
peptide chains 
(from Streptomyces 
roseosporus and 
Bacillus polymyxa) 
 
Gram-positive 
species 
(daptomycin), 
Gram-negative 
species 
(polymixins) 
Cell membrane Cell wall synthesis and 
envelope two-
component systems 
Aminoglycosides      
Protein 
synthesis 
inhibitors 
Gentamicin, 
tobramycin, 
streptomycin and 
kanamycin 
Natural and semi-
synthetic forms of 
amino sugars (-
mycins from 
Streptomyces spp. 
and-micins from 
Micromonospora 
sp.) 
Aerobic Gram-
positive and Gram-
negative species, 
and 
Mycobacterium 
tuberculosis 
30S ribosome Protein translation 
(mistranslation by tRNA 
mismatching), Electron 
transport chain, SOS 
response, Tricarboxylic 
acid cycle, Fe–S 
cluster synthesis, 
Reactive oxygen species 
formation, and envelope 
and redox-responsive 
two-component systems 
Tetracyclines      
Protein 
synthesis 
inhibitors 
Tetracycline and 
doxycycline 
Natural and semi-
synthetic forms of 
four-ringed 
polyketides (from 
Streptomyces 
aureofaciens and 
Streptomyces 
rimosus) 
Aerobic Gram-
positive and Gram-
negative species 
30S ribosome Protein translation 
(through inhibition of 
aminoacyl tRNA 
binding to ribosome) 
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Table 2.2 Continued 
Class Drug Derivation Species range Primary target Pathway affected 
Macrolides      
Protein 
synthesis 
inhibitors 
Erythromycin and 
azythromycin 
Natural and semi-
synthetic forms of 
14- and 16 
membered 
lactone rings (from 
Saccharopolyspora 
erythraea 
and Streptomyces 
ambofaciens) 
 
Aerobic and 
anaerobic 
Gram-positive and 
Gram-negative 
species 
50S ribosome Protein translation 
(through inhibition 
of elongation and 
translocation steps) 
and free tRNA 
depletion 
**Sulfonamides      
Metabolic pathway 
inhibitor 
Sulfamethoxazole, 
trimethoprim 
Synthetic Aerobic Gram-
positive and Gram-
negative species 
Folate synthesis Biosynthesis of 
nucleotides 
(building block of 
DNA and RNA) 
 
 
Source: **Dzidic et al. (2008); Kohanski et al. (2010) 
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2.4 Antioxidant activity 
 
Antioxidant is referred to the compounds or substances that are able to prevent or 
minimize oxidative damages to the body tissues (Scheibmeir et al., 2005). 
Generally, they are two types of antioxidant which are natural and synthetic 
antioxidant. Natural antioxidants are generally refers to the compounds which 
originated from natural products such as phenolics, nitrogen compounds and 
carotenoids (Nandita and Ranjini, 2004). Synthetic antioxidants are commonly used 
in food processing as food preservatives (Zhang et al., 2010). Most common 
commercialized synthetic antioxidant like butylated hydroxytoluene (BHT) and 
butylated hydroxyanisole (BHA) are used to prolong the storage life-span of food. 
 
Antioxidant can be classified into two categories, based on their mechanism of 
action which is chain-breaking antioxidants and preventive antioxidant. The chain-
breaking antioxidant acts by breaking the formation chain of the free radical by 
giving up an electron to the free radical and stabilize the free radicals. On the other 
hand, the preventive antioxidants inhibit or delay the oxidation process by 
scavenging the reactive oxygen species. There are three crucial enzymes needed in 
scavenging the reactive species namely, superoxide dismutase, catalase and 
glutathione (Scheibmeir et al., 2005). 
 
2.4.1 Oxidative damage and diseases 
 
Free radical denotes to any atoms with a single unpaired electron in the outermost 
shell that formed from the splitting of the weak bonds (Gutteridge and Mitchell, 
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1999). Free radicals are unstable and highly reactive as it tends to pair up with other 
electron to gain stability. The unpaired electron is responsible in causing cellular 
damage and disruptions of biological function by attacking macromolecules such as 
lipids, proteins, DNA and carbohydrates through lipid peroxidation (Kuhn, 2003; 
Wu and Cederbaum, 2003). Thus, presence of antioxidant in the body will helps in 
combating the free radicals.  
 
Free radicals are produced by aerobic metabolic reactions of the body (Gutteridge, 
1994), which resulted into two major types of free radicals being produced; reactive 
oxygen species (ROS) and reactive nitrogen species (RNS). According to 
Scheibmeir et al. (2005), reactive oxygen species (ROS) such as superoxide anion 
(O2 -) and its derivatives; hydroxyl radical (OH) and hydrogen peroxide (H2O2), are 
produced through reduction of triplet oxygen species. This reduction reaction that 
occurrs during electron transport chain (ETC) process in mitochondria require an 
enzyme called NADPH oxidase. The hydroxyl radical (OH) produced is responsible 
in damaging cell membrane and lipoproteins through lipid peroxidation that leads to 
artherosclerosis (Kerr et al., 1996). The formation of the ROS types and its 
derivatives is illustrated in Figure 2.1. 
 
 
 
 
 
 
Figure 2.1  Formation of reactive oxygen species (ROS) and its derivatives. 
(Source: Scheibmeir et al., 2005) 
Major ROS 
 
  O2                       O2-                       H2O2                        OH                      H2O 
Oxygen        Superoxide                Hydrogen                Hydroxyl                Water 
                         Anion                     Peroxide                   Radical 
                                          
 
 
            
Broken down into 
oxygen and water by 
cellular enzyme catalase 
An electron is added 
 
Superoxide dismutase       Catalase       Glutathione 
ROS Scavengers 
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Reactive nitrogen species (RNS) called nitric oxide (NO) and its derivatives; 
nitrosonium cation (NO+), nitroxyl anion (NO-) and peroxynitrile (ONOO-) are 
produced through an oxidative process of an L-arginine terminal nitrogen atom 
(Palmer et al., 1988; Stamler et al., 1992). On the bright side, not all free radicals are 
bad for body. Some of the free radicals that produced by body through metabolism 
reactions involved in important physiological functions as shown in Table 2.3. Liver 
for example, use free radical for detoxification and neutrophils produced free 
radicals to destroy the pathogens (Lunec et al., 2002).  
 
Table 2.3 Important physiological functions involves free radicals or their  
     derivatives 
 
 
*ROS; Reactive oxygen species. (Source: Droge, 2002). 
 
 
However, unavailability of antioxidants or excessive production of free radicals in 
the body will lead to oxidative stress condition (Li et al., 2009). This condition is 
responsible for development of diseases such as heart disease, congestive heart 
failure, Alzheimer’s disease, ageing, liver damages, cancer and others (Duan et al., 
2006).   
 
Type of radical Source of radical Physiological process 
Superoxide anion (O2-)  
and related ROS 
NADPH oxidase Control of erythropoietin 
production; hypoxia-
inducible functions; smooth 
muscle relaxation 
Superoxide anion (O2-)  
and related ROS 
Any source 
 
Oxidative stress responses; 
maintenance of redox 
homeostasis 
Nitric oxide (NO) Nitric oxide synthase Smooth muscle relaxation 
(control of vascular tone); 
cGMP-dependent functions 
